These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 3740545)
21. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Strano A; Davi G; Avellone G; Novo S; Pinto A Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350 [TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease. Trübestein G; Trübestein R; Duong QD Angiology; 1981 Oct; 32(10):705-10. PubMed ID: 7034591 [TBL] [Abstract][Full Text] [Related]
23. Effects of pentoxifylline on severe intermittent claudication. Reich T; Gillings D Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744 [TBL] [Abstract][Full Text] [Related]
24. [Training by walking and drug therapy of peripheral arterial occlusive disease]. Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495 [No Abstract] [Full Text] [Related]
25. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease. Perego MA; Sergio G; Artale F; Giunti P; Danese C Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212 [TBL] [Abstract][Full Text] [Related]
26. Results of clinical, laboratory and haemorheological investigations of the use of pentoxifylline in high doses. Antignani PL; Todini AR; Saliceti F; Pacino G; Bartolo M Pharmatherapeutica; 1987; 5(1):50-6. PubMed ID: 3602022 [TBL] [Abstract][Full Text] [Related]
27. [Effect of a transient intravenous infusion of isozsuprin on the peripheral blood flow in patients suffering from arterial occlusive disease of the limbs. A contribution to the effect of systemically-administered vasoactive drugs]. Ehringer H; Scheiber V Wien Klin Wochenschr; 1972 Dec; 24(50):801-8. PubMed ID: 4642105 [No Abstract] [Full Text] [Related]
28. Studies of the clinical pharmacology and therapeutic efficacy of pentoxifylline in peripheral obstructive arterial disease. Di Perri T; Carandente O; Vittoria A; Guerrini M; Messa GL Angiology; 1984 Jul; 35(7):427-35. PubMed ID: 6540539 [TBL] [Abstract][Full Text] [Related]
29. Determinants of response to pentoxifylline therapy in patients with intermittent claudication. Thomas JH; Swannack CJ; McAnaw M; Klein S; Kinnaman ML; Iliopoulos JI; Hermreck AS; Pierce GE Am J Surg; 1987 Dec; 154(6):663-5. PubMed ID: 3425814 [TBL] [Abstract][Full Text] [Related]
30. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value]. Benignetti G; Fabbri F; Benvenuti C Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465 [No Abstract] [Full Text] [Related]
31. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study. Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200 [TBL] [Abstract][Full Text] [Related]
32. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases]. Giansante C; Di Chiara A; Fiotti N; Mauri F; Sorrentino A; Spanghero M; Tomasin L; Calabrese S Clin Ter; 1990 Sep; 134(5):301-5. PubMed ID: 2149312 [TBL] [Abstract][Full Text] [Related]
33. [Clinical pharmacology of vasoactive substances: study on pentoxifylline]. Pupita F; Rotatori P; Frausini G Ric Clin Lab; 1981; 11 Suppl 1():293-302. PubMed ID: 7188116 [No Abstract] [Full Text] [Related]
34. Clinical results of pentoxifylline use in a community peripheral vascular surgical practice. Smith MA; Fish RC Monogr Atheroscler; 1990; 15():27-9. PubMed ID: 2296248 [No Abstract] [Full Text] [Related]
35. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training. Scheffler P; de la Hamette D; Gross J; Mueller H; Schieffer H Circulation; 1994 Aug; 90(2):818-22. PubMed ID: 8044953 [TBL] [Abstract][Full Text] [Related]
36. Short-range intermittent claudication and rest pain: microcirculatory effects of pentoxifylline in a randomized, controlled trial. Incandela L; De Sanctis MT; Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Ramaswami G Angiology; 2002; 53 Suppl 1():S27-30. PubMed ID: 11865832 [TBL] [Abstract][Full Text] [Related]
37. [Effectiveness of intravenous infusion treatment of peripheral arterial occlusive disease with Trental--results of a multicenter double-blind study]. Rudofsky G; Haussler KF; Künkel HP; Schneider-May H; Spengel F; Symann O; Werner HJ; Rössner M Vasa Suppl; 1987; 20():375-8. PubMed ID: 3321494 [No Abstract] [Full Text] [Related]
38. The effect of pentoxifylline on circulatory disturbances of the retina and optic nerve. A report of ten years clinical experience. Küchle HJ; Richard G Ric Clin Lab; 1981; 11 Suppl 1():333-43. PubMed ID: 7188121 [TBL] [Abstract][Full Text] [Related]
39. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial. Arosio E; De Marchi S; Zannoni M; Prior M; Lechi A Mayo Clin Proc; 2002 Aug; 77(8):754-9. PubMed ID: 12173710 [TBL] [Abstract][Full Text] [Related]
40. Effects and limitations of pentoxifylline therapy in various stages of peripheral vascular disease of the lower extremity. AbuRahma AF; Woodruff BA Am J Surg; 1990 Sep; 160(3):266-70. PubMed ID: 2393054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]